Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 — a systematic review and meta-analyses
| Parent link: | BMC Infectious Diseases.— .— New York: BioMed Central (Springer Nature) Vol. 25.— 2025.— Article number 719, 22 p. |
|---|---|
| Other Authors: | , , , , , , |
| Summary: | Title screen The COVID-19 pandemic has posed significant challenges to global health, with type 2 diabetes mellitus (T2DM) emerging as a key risk factor for adverse outcomes. This study systematically reviews and quantifies the association between T2DM and COVID-19 outcomes, including mortality, severity, and need for mechanical ventilation Текстовый файл |
| Language: | English |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-11089-w |
| Format: | Electronic Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=682958 |